Literature DB >> 7469654

Pharmacological screening of the aqueous extracts of Magnolia grandiflora L.

V Mellado, M A Chavez Soto, X Lozoya.   

Abstract

Preliminary screening studies of the aqueous extracts of flowers and leaves of Magnolia grandiflora L. were carried out on different animal models in an attempt to confirm their effects on the cardiovascular system, in view of the wide use of this plant in traditional Mexican medicine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7469654

Source DB:  PubMed          Journal:  Arch Invest Med (Mex)        ISSN: 0066-6769


  2 in total

1.  Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice.

Authors:  C R Chen; R Tan; W M Qu; Z Wu; Y Wang; Y Urade; Z L Huang
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

2.  Inhibition of melanogenesis and antioxidant properties of Magnolia grandiflora L. flower extract.

Authors:  Huey-Chun Huang; Wan-Yu Hsieh; Yu-Lin Niu; Tsong-Min Chang
Journal:  BMC Complement Altern Med       Date:  2012-06-06       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.